nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—TCN1—gastric juice—esophageal cancer	0.104	0.32	CbGeAlD
Hydroxocobalamin—TCN1—exocrine gland—esophageal cancer	0.0192	0.0589	CbGeAlD
Hydroxocobalamin—Venous thrombosis—Carboplatin—esophageal cancer	0.0165	0.079	CcSEcCtD
Hydroxocobalamin—Fluid overload—Carboplatin—esophageal cancer	0.0143	0.0685	CcSEcCtD
Hydroxocobalamin—AMN—bronchus—esophageal cancer	0.0109	0.0333	CbGeAlD
Hydroxocobalamin—Extravasation—Carboplatin—esophageal cancer	0.0102	0.0488	CcSEcCtD
Hydroxocobalamin—CUBN—epithelium—esophageal cancer	0.00927	0.0285	CbGeAlD
Hydroxocobalamin—MUT—neck—esophageal cancer	0.00867	0.0266	CbGeAlD
Hydroxocobalamin—MMACHC—lung—esophageal cancer	0.0085	0.0261	CbGeAlD
Hydroxocobalamin—AMN—digestive system—esophageal cancer	0.00838	0.0257	CbGeAlD
Hydroxocobalamin—TCN1—bronchus—esophageal cancer	0.00822	0.0252	CbGeAlD
Hydroxocobalamin—Haemolysis—Cisplatin—esophageal cancer	0.00821	0.0393	CcSEcCtD
Hydroxocobalamin—MMAB—bronchus—esophageal cancer	0.0081	0.0249	CbGeAlD
Hydroxocobalamin—Phlebitis—Carboplatin—esophageal cancer	0.0075	0.0359	CcSEcCtD
Hydroxocobalamin—TCN1—trachea—esophageal cancer	0.00738	0.0227	CbGeAlD
Hydroxocobalamin—CUBN—digestive system—esophageal cancer	0.00706	0.0216	CbGeAlD
Hydroxocobalamin—AMN—lung—esophageal cancer	0.007	0.0215	CbGeAlD
Hydroxocobalamin—TCN1—digestive system—esophageal cancer	0.00635	0.0195	CbGeAlD
Hydroxocobalamin—MUT—bronchus—esophageal cancer	0.00581	0.0178	CbGeAlD
Hydroxocobalamin—TCN2—digestive system—esophageal cancer	0.00571	0.0175	CbGeAlD
Hydroxocobalamin—MMAA—lung—esophageal cancer	0.00557	0.0171	CbGeAlD
Hydroxocobalamin—Chromaturia—Capecitabine—esophageal cancer	0.00539	0.0258	CcSEcCtD
Hydroxocobalamin—TCN1—lung—esophageal cancer	0.00531	0.0163	CbGeAlD
Hydroxocobalamin—MMAB—lung—esophageal cancer	0.00523	0.016	CbGeAlD
Hydroxocobalamin—MTRR—bronchus—esophageal cancer	0.00522	0.016	CbGeAlD
Hydroxocobalamin—MUT—trachea—esophageal cancer	0.00522	0.016	CbGeAlD
Hydroxocobalamin—CASP9—lung—esophageal cancer	0.00488	0.015	CbGeAlD
Hydroxocobalamin—Venous thrombosis—Cisplatin—esophageal cancer	0.00484	0.0232	CcSEcCtD
Hydroxocobalamin—AMN—lymph node—esophageal cancer	0.00479	0.0147	CbGeAlD
Hydroxocobalamin—Haematochezia—Capecitabine—esophageal cancer	0.00478	0.0229	CcSEcCtD
Hydroxocobalamin—TCN2—lung—esophageal cancer	0.00477	0.0146	CbGeAlD
Hydroxocobalamin—MTRR—trachea—esophageal cancer	0.00469	0.0144	CbGeAlD
Hydroxocobalamin—MTR—bronchus—esophageal cancer	0.00455	0.014	CbGeAlD
Hydroxocobalamin—MUT—digestive system—esophageal cancer	0.00449	0.0138	CbGeAlD
Hydroxocobalamin—Fluid overload—Cisplatin—esophageal cancer	0.0042	0.0201	CcSEcCtD
Hydroxocobalamin—MTR—trachea—esophageal cancer	0.00409	0.0125	CbGeAlD
Hydroxocobalamin—MTRR—digestive system—esophageal cancer	0.00403	0.0124	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—esophageal cancer	0.00403	0.0124	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—esophageal cancer	0.00381	0.0117	CbGeAlD
Hydroxocobalamin—MUT—lung—esophageal cancer	0.00375	0.0115	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—esophageal cancer	0.00357	0.011	CbGeAlD
Hydroxocobalamin—Venous thrombosis—Capecitabine—esophageal cancer	0.00357	0.0171	CcSEcCtD
Hydroxocobalamin—MTR—digestive system—esophageal cancer	0.00352	0.0108	CbGeAlD
Hydroxocobalamin—MTRR—lung—esophageal cancer	0.00337	0.0103	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—esophageal cancer	0.00334	0.0102	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—esophageal cancer	0.00326	0.01	CbGeAlD
Hydroxocobalamin—Infection—Carboplatin—esophageal cancer	0.00316	0.0151	CcSEcCtD
Hydroxocobalamin—Extravasation—Cisplatin—esophageal cancer	0.00299	0.0143	CcSEcCtD
Hydroxocobalamin—MTR—lung—esophageal cancer	0.00294	0.00901	CbGeAlD
Hydroxocobalamin—Thrombosis—Capecitabine—esophageal cancer	0.00272	0.013	CcSEcCtD
Hydroxocobalamin—Pain—Carboplatin—esophageal cancer	0.00272	0.013	CcSEcCtD
Hydroxocobalamin—MUT—lymph node—esophageal cancer	0.00256	0.00786	CbGeAlD
Hydroxocobalamin—Pleural effusion—Capecitabine—esophageal cancer	0.00251	0.012	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Carboplatin—esophageal cancer	0.00251	0.012	CcSEcCtD
Hydroxocobalamin—Memory impairment—Capecitabine—esophageal cancer	0.00245	0.0117	CcSEcCtD
Hydroxocobalamin—MTRR—lymph node—esophageal cancer	0.0023	0.00707	CbGeAlD
Hydroxocobalamin—Folliculitis—Methotrexate—esophageal cancer	0.00228	0.0109	CcSEcCtD
Hydroxocobalamin—Phlebitis—Cisplatin—esophageal cancer	0.0022	0.0105	CcSEcCtD
Hydroxocobalamin—Chest discomfort—Capecitabine—esophageal cancer	0.00218	0.0104	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00213	0.0102	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00209	0.01	CcSEcCtD
Hydroxocobalamin—Lung disorder—Methotrexate—esophageal cancer	0.00202	0.00969	CcSEcCtD
Hydroxocobalamin—MTR—lymph node—esophageal cancer	0.00201	0.00616	CbGeAlD
Hydroxocobalamin—Blood pressure increased—Capecitabine—esophageal cancer	0.00193	0.00922	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Capecitabine—esophageal cancer	0.00191	0.00916	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Cisplatin—esophageal cancer	0.0019	0.00911	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Methotrexate—esophageal cancer	0.00187	0.00896	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Cisplatin—esophageal cancer	0.00173	0.00826	CcSEcCtD
Hydroxocobalamin—Extravasation—Methotrexate—esophageal cancer	0.00164	0.00786	CcSEcCtD
Hydroxocobalamin—Phlebitis—Capecitabine—esophageal cancer	0.00162	0.00776	CcSEcCtD
Hydroxocobalamin—Swelling—Capecitabine—esophageal cancer	0.00158	0.00758	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Cisplatin—esophageal cancer	0.00157	0.00752	CcSEcCtD
Hydroxocobalamin—Hot flush—Capecitabine—esophageal cancer	0.00149	0.00715	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Capecitabine—esophageal cancer	0.00148	0.00709	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Capecitabine—esophageal cancer	0.00146	0.007	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Capecitabine—esophageal cancer	0.0014	0.00672	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Capecitabine—esophageal cancer	0.00133	0.00636	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Cisplatin—esophageal cancer	0.0013	0.0062	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Cisplatin—esophageal cancer	0.00129	0.00615	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Methotrexate—esophageal cancer	0.00128	0.00611	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Capecitabine—esophageal cancer	0.00127	0.00609	CcSEcCtD
Hydroxocobalamin—Eye disorder—Cisplatin—esophageal cancer	0.00123	0.00587	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Cisplatin—esophageal cancer	0.00122	0.00583	CcSEcCtD
Hydroxocobalamin—Dysphagia—Capecitabine—esophageal cancer	0.00121	0.00578	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Cisplatin—esophageal cancer	0.00118	0.00567	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Cisplatin—esophageal cancer	0.00118	0.00566	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Cisplatin—esophageal cancer	0.00117	0.00561	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Capecitabine—esophageal cancer	0.00116	0.00554	CcSEcCtD
Hydroxocobalamin—Erythema—Cisplatin—esophageal cancer	0.00114	0.00546	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Cisplatin—esophageal cancer	0.00106	0.00507	CcSEcCtD
Hydroxocobalamin—Malaise—Cisplatin—esophageal cancer	0.00103	0.00493	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000965	0.00462	CcSEcCtD
Hydroxocobalamin—Discomfort—Cisplatin—esophageal cancer	0.00096	0.0046	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000955	0.00457	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Capecitabine—esophageal cancer	0.000952	0.00456	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Capecitabine—esophageal cancer	0.000948	0.00454	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000932	0.00446	CcSEcCtD
Hydroxocobalamin—Oedema—Cisplatin—esophageal cancer	0.000932	0.00446	CcSEcCtD
Hydroxocobalamin—Infection—Cisplatin—esophageal cancer	0.000926	0.00443	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Cisplatin—esophageal cancer	0.000914	0.00437	CcSEcCtD
Hydroxocobalamin—Tachycardia—Cisplatin—esophageal cancer	0.000909	0.00435	CcSEcCtD
Hydroxocobalamin—Skin disorder—Cisplatin—esophageal cancer	0.000905	0.00433	CcSEcCtD
Hydroxocobalamin—Eye disorder—Capecitabine—esophageal cancer	0.000903	0.00432	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Capecitabine—esophageal cancer	0.000897	0.00429	CcSEcCtD
Hydroxocobalamin—Angiopathy—Capecitabine—esophageal cancer	0.000877	0.0042	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Capecitabine—esophageal cancer	0.000873	0.00418	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000871	0.00417	CcSEcCtD
Hydroxocobalamin—Chills—Capecitabine—esophageal cancer	0.000867	0.00415	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Capecitabine—esophageal cancer	0.000864	0.00413	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000862	0.00413	CcSEcCtD
Hydroxocobalamin—Mental disorder—Capecitabine—esophageal cancer	0.000847	0.00405	CcSEcCtD
Hydroxocobalamin—Erythema—Capecitabine—esophageal cancer	0.000842	0.00403	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Cisplatin—esophageal cancer	0.000831	0.00398	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000804	0.00385	CcSEcCtD
Hydroxocobalamin—Pain—Cisplatin—esophageal cancer	0.000797	0.00381	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000781	0.00374	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Cisplatin—esophageal cancer	0.000768	0.00368	CcSEcCtD
Hydroxocobalamin—Malaise—Capecitabine—esophageal cancer	0.000759	0.00363	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Cisplatin—esophageal cancer	0.000737	0.00353	CcSEcCtD
Hydroxocobalamin—Chest pain—Capecitabine—esophageal cancer	0.000716	0.00343	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000712	0.00341	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000711	0.0034	CcSEcCtD
Hydroxocobalamin—Discomfort—Capecitabine—esophageal cancer	0.000708	0.00339	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Methotrexate—esophageal cancer	0.000705	0.00338	CcSEcCtD
Hydroxocobalamin—Oedema—Capecitabine—esophageal cancer	0.000687	0.00329	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Cisplatin—esophageal cancer	0.000686	0.00329	CcSEcCtD
Hydroxocobalamin—Infection—Capecitabine—esophageal cancer	0.000682	0.00327	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Capecitabine—esophageal cancer	0.000674	0.00322	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—esophageal cancer	0.000673	0.00322	CcSEcCtD
Hydroxocobalamin—Tachycardia—Capecitabine—esophageal cancer	0.00067	0.00321	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—esophageal cancer	0.000668	0.0032	CcSEcCtD
Hydroxocobalamin—Skin disorder—Capecitabine—esophageal cancer	0.000667	0.00319	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—esophageal cancer	0.000653	0.00313	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—esophageal cancer	0.00065	0.00311	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—esophageal cancer	0.000649	0.0031	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—esophageal cancer	0.000646	0.00309	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Cisplatin—esophageal cancer	0.000637	0.00305	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—esophageal cancer	0.00063	0.00302	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—esophageal cancer	0.000626	0.003	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Capecitabine—esophageal cancer	0.000612	0.00293	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Capecitabine—esophageal cancer	0.000605	0.00289	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000593	0.00284	CcSEcCtD
Hydroxocobalamin—Rash—Cisplatin—esophageal cancer	0.000587	0.00281	CcSEcCtD
Hydroxocobalamin—Pain—Capecitabine—esophageal cancer	0.000587	0.00281	CcSEcCtD
Hydroxocobalamin—Dermatitis—Cisplatin—esophageal cancer	0.000587	0.00281	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000581	0.00278	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Capecitabine—esophageal cancer	0.000566	0.00271	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—esophageal cancer	0.000565	0.0027	CcSEcCtD
Hydroxocobalamin—Nausea—Cisplatin—esophageal cancer	0.000553	0.00265	CcSEcCtD
Hydroxocobalamin—Urticaria—Capecitabine—esophageal cancer	0.000546	0.00261	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Capecitabine—esophageal cancer	0.000543	0.0026	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—esophageal cancer	0.000533	0.00255	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00053	0.00254	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—esophageal cancer	0.000527	0.00252	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000511	0.00245	CcSEcCtD
Hydroxocobalamin—Infection—Methotrexate—esophageal cancer	0.000508	0.00243	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Capecitabine—esophageal cancer	0.000506	0.00242	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—esophageal cancer	0.000501	0.0024	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—esophageal cancer	0.000497	0.00238	CcSEcCtD
Hydroxocobalamin—Pruritus—Capecitabine—esophageal cancer	0.000486	0.00233	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Capecitabine—esophageal cancer	0.00047	0.00225	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Methotrexate—esophageal cancer	0.000456	0.00218	CcSEcCtD
Hydroxocobalamin—Dizziness—Capecitabine—esophageal cancer	0.000454	0.00217	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Methotrexate—esophageal cancer	0.00045	0.00215	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000441	0.00211	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—esophageal cancer	0.000437	0.00209	CcSEcCtD
Hydroxocobalamin—Rash—Capecitabine—esophageal cancer	0.000433	0.00207	CcSEcCtD
Hydroxocobalamin—Dermatitis—Capecitabine—esophageal cancer	0.000433	0.00207	CcSEcCtD
Hydroxocobalamin—Headache—Capecitabine—esophageal cancer	0.00043	0.00206	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methotrexate—esophageal cancer	0.000421	0.00202	CcSEcCtD
Hydroxocobalamin—Nausea—Capecitabine—esophageal cancer	0.000408	0.00195	CcSEcCtD
Hydroxocobalamin—Urticaria—Methotrexate—esophageal cancer	0.000406	0.00194	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—esophageal cancer	0.000404	0.00193	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methotrexate—esophageal cancer	0.000377	0.0018	CcSEcCtD
Hydroxocobalamin—Pruritus—Methotrexate—esophageal cancer	0.000362	0.00173	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—esophageal cancer	0.00035	0.00167	CcSEcCtD
Hydroxocobalamin—Dizziness—Methotrexate—esophageal cancer	0.000338	0.00162	CcSEcCtD
Hydroxocobalamin—Rash—Methotrexate—esophageal cancer	0.000322	0.00154	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—esophageal cancer	0.000322	0.00154	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—esophageal cancer	0.00032	0.00153	CcSEcCtD
Hydroxocobalamin—Nausea—Methotrexate—esophageal cancer	0.000304	0.00145	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 interactions—PIK3CA—esophageal cancer	0.000113	0.000243	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—XIAP—esophageal cancer	0.000113	0.000242	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NOS2—esophageal cancer	0.000112	0.000242	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—PIK3CA—esophageal cancer	0.000112	0.000241	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ENO1—esophageal cancer	0.000112	0.00024	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS1—esophageal cancer	0.000112	0.00024	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NOTCH1—esophageal cancer	0.000111	0.000239	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—PIK3CA—esophageal cancer	0.000111	0.000239	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—PIK3CA—esophageal cancer	0.000111	0.000238	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PFN1—esophageal cancer	0.00011	0.000237	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PSME2—esophageal cancer	0.00011	0.000236	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PSME1—esophageal cancer	0.00011	0.000236	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—CDKN1A—esophageal cancer	0.00011	0.000236	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CYP19A1—esophageal cancer	0.000109	0.000235	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PSME1—esophageal cancer	0.000107	0.00023	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PSME2—esophageal cancer	0.000107	0.00023	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—CREBBP—esophageal cancer	0.000107	0.00023	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—CREBBP—esophageal cancer	0.000107	0.00023	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—ERBB2—esophageal cancer	0.000107	0.00023	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—ERBB2—esophageal cancer	0.000107	0.00023	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000107	0.000229	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NOS3—esophageal cancer	0.000106	0.000229	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HSPA5—esophageal cancer	0.000106	0.000228	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CREBBP—esophageal cancer	0.000106	0.000227	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CREBBP—esophageal cancer	0.000106	0.000227	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—PIK3CA—esophageal cancer	0.000105	0.000225	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—NOS3—esophageal cancer	0.000105	0.000225	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—B2M—esophageal cancer	0.000105	0.000225	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTGS2—esophageal cancer	0.000105	0.000225	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PTGS2—esophageal cancer	0.000105	0.000225	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NOS2—esophageal cancer	0.000104	0.000223	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000103	0.000222	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CALR—esophageal cancer	0.000103	0.000221	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NOTCH1—esophageal cancer	0.000103	0.000221	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—TLR4—esophageal cancer	0.000102	0.00022	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CREBBP—esophageal cancer	0.000101	0.000217	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ENO1—esophageal cancer	0.0001	0.000216	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—PIK3CA—esophageal cancer	0.0001	0.000216	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.0001	0.000216	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.0001	0.000216	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—CDKN1A—esophageal cancer	9.99e-05	0.000215	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—HMOX1—esophageal cancer	9.99e-05	0.000215	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—CREBBP—esophageal cancer	9.94e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—ERBB2—esophageal cancer	9.94e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FBXW7—esophageal cancer	9.94e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ELMO1—esophageal cancer	9.89e-05	0.000213	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PSME2—esophageal cancer	9.89e-05	0.000213	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PSME1—esophageal cancer	9.89e-05	0.000213	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFBR2—esophageal cancer	9.86e-05	0.000212	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—esophageal cancer	9.72e-05	0.000209	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKAP13—esophageal cancer	9.67e-05	0.000208	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ABCB1—esophageal cancer	9.59e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—NOS3—esophageal cancer	9.58e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—NOS3—esophageal cancer	9.58e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—esophageal cancer	9.58e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.56e-05	0.000206	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EP300—esophageal cancer	9.51e-05	0.000204	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HMGB1—esophageal cancer	9.5e-05	0.000204	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP1B1—esophageal cancer	9.49e-05	0.000204	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CALR—esophageal cancer	9.49e-05	0.000204	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NOS3—esophageal cancer	9.47e-05	0.000204	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NOS3—esophageal cancer	9.47e-05	0.000204	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HIF1A—esophageal cancer	9.37e-05	0.000201	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SMAD4—esophageal cancer	9.33e-05	0.000201	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CREBBP—esophageal cancer	9.32e-05	0.0002	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FBXW7—esophageal cancer	9.18e-05	0.000197	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—CDKN1A—esophageal cancer	9.14e-05	0.000197	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—CDKN1A—esophageal cancer	9.14e-05	0.000197	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NOS3—esophageal cancer	9.04e-05	0.000194	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIST1H2BM—esophageal cancer	8.92e-05	0.000192	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CYP19A1—esophageal cancer	8.92e-05	0.000192	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—NOS3—esophageal cancer	8.9e-05	0.000191	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—EGFR—esophageal cancer	8.89e-05	0.000191	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—CREBBP—esophageal cancer	8.86e-05	0.000191	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—CREBBP—esophageal cancer	8.86e-05	0.000191	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—ERBB2—esophageal cancer	8.86e-05	0.000191	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ERBB2—esophageal cancer	8.86e-05	0.000191	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDE4D—esophageal cancer	8.84e-05	0.00019	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.83e-05	0.00019	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CASP8—esophageal cancer	8.77e-05	0.000189	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—esophageal cancer	8.76e-05	0.000188	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—esophageal cancer	8.76e-05	0.000188	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CREBBP—esophageal cancer	8.73e-05	0.000188	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EP300—esophageal cancer	8.7e-05	0.000187	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EP300—esophageal cancer	8.7e-05	0.000187	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—esophageal cancer	8.67e-05	0.000186	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PTGS2—esophageal cancer	8.67e-05	0.000186	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS2—esophageal cancer	8.52e-05	0.000183	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—CDKN1A—esophageal cancer	8.5e-05	0.000183	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—CREBBP—esophageal cancer	8.45e-05	0.000182	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—ERBB2—esophageal cancer	8.45e-05	0.000182	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOTCH1—esophageal cancer	8.44e-05	0.000181	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GNG7—esophageal cancer	8.41e-05	0.000181	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NOS3—esophageal cancer	8.34e-05	0.000179	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MYC—esophageal cancer	8.29e-05	0.000178	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—esophageal cancer	8.27e-05	0.000178	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—esophageal cancer	8.14e-05	0.000175	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—HMOX1—esophageal cancer	8.14e-05	0.000175	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EGFR—esophageal cancer	8.11e-05	0.000174	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EP300—esophageal cancer	8.09e-05	0.000174	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—EP300—esophageal cancer	7.96e-05	0.000171	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—NOS3—esophageal cancer	7.93e-05	0.000171	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—NOS3—esophageal cancer	7.93e-05	0.000171	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—XIAP—esophageal cancer	7.88e-05	0.000169	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ABL1—esophageal cancer	7.86e-05	0.000169	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ABCB1—esophageal cancer	7.81e-05	0.000168	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CREBBP—esophageal cancer	7.8e-05	0.000168	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ERBB2—esophageal cancer	7.8e-05	0.000168	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—PIK3CA—esophageal cancer	7.71e-05	0.000166	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CREBBP—esophageal cancer	7.65e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HIF1A—esophageal cancer	7.64e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—esophageal cancer	7.63e-05	0.000164	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MYC—esophageal cancer	7.58e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MYC—esophageal cancer	7.58e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—CDKN1A—esophageal cancer	7.57e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—CDKN1A—esophageal cancer	7.57e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—NOS3—esophageal cancer	7.57e-05	0.000163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—BCL2—esophageal cancer	7.53e-05	0.000162	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNA1—esophageal cancer	7.45e-05	0.00016	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFBR2—esophageal cancer	7.42e-05	0.00016	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—esophageal cancer	7.41e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—esophageal cancer	7.41e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL2—esophageal cancer	7.41e-05	0.000159	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—ERBB2—esophageal cancer	7.31e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—EP300—esophageal cancer	7.28e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—EP300—esophageal cancer	7.28e-05	0.000157	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—esophageal cancer	7.26e-05	0.000156	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—esophageal cancer	7.26e-05	0.000156	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—CDKN1A—esophageal cancer	7.23e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EP300—esophageal cancer	7.21e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EP300—esophageal cancer	7.21e-05	0.000155	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MYC—esophageal cancer	7.05e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PIK3CA—esophageal cancer	7.03e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SMAD4—esophageal cancer	7.03e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ERBB2—esophageal cancer	7.02e-05	0.000151	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—NOS3—esophageal cancer	6.99e-05	0.00015	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS2—esophageal cancer	6.95e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PSME2—esophageal cancer	6.92e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PSME1—esophageal cancer	6.92e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—esophageal cancer	6.92e-05	0.000149	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—esophageal cancer	6.89e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ANXA1—esophageal cancer	6.89e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOTCH1—esophageal cancer	6.88e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EP300—esophageal cancer	6.88e-05	0.000148	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS3—esophageal cancer	6.85e-05	0.000147	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—EP300—esophageal cancer	6.77e-05	0.000146	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SST—esophageal cancer	6.7e-05	0.000144	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—CDKN1A—esophageal cancer	6.67e-05	0.000143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH3—esophageal cancer	6.53e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GHRL—esophageal cancer	6.53e-05	0.00014	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PIK3CA—esophageal cancer	6.43e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PIK3CA—esophageal cancer	6.43e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FBXW7—esophageal cancer	6.43e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CREBBP—esophageal cancer	6.41e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—ERBB2—esophageal cancer	6.41e-05	0.000138	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—esophageal cancer	6.39e-05	0.000137	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EP300—esophageal cancer	6.34e-05	0.000136	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MYC—esophageal cancer	6.28e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MYC—esophageal cancer	6.28e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—esophageal cancer	6.26e-05	0.000135	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CDKN1A—esophageal cancer	6.25e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CREBBP—esophageal cancer	6.24e-05	0.000134	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—esophageal cancer	6.14e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—esophageal cancer	6.14e-05	0.000132	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—EP300—esophageal cancer	6.04e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—EP300—esophageal cancer	6.04e-05	0.00013	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDKN1A—esophageal cancer	6e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—esophageal cancer	5.99e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—esophageal cancer	5.98e-05	0.000129	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TLR4—esophageal cancer	5.95e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EP300—esophageal cancer	5.95e-05	0.000128	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—esophageal cancer	5.89e-05	0.000127	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—esophageal cancer	5.86e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH2—esophageal cancer	5.86e-05	0.000126	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—EP300—esophageal cancer	5.76e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HIF1A—esophageal cancer	5.75e-05	0.000124	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—NOS3—esophageal cancer	5.74e-05	0.000123	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS3—esophageal cancer	5.58e-05	0.00012	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—esophageal cancer	5.53e-05	0.000119	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1A—esophageal cancer	5.48e-05	0.000118	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—esophageal cancer	5.41e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—esophageal cancer	5.39e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—esophageal cancer	5.39e-05	0.000116	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—esophageal cancer	5.33e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—esophageal cancer	5.33e-05	0.000115	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—EP300—esophageal cancer	5.31e-05	0.000114	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—esophageal cancer	5.25e-05	0.000113	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS2—esophageal cancer	5.23e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CREBBP—esophageal cancer	5.22e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—esophageal cancer	5.22e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EP300—esophageal cancer	5.21e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFBR2—esophageal cancer	5.2e-05	0.000112	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOTCH1—esophageal cancer	5.18e-05	0.000111	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CASP8—esophageal cancer	5.11e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—esophageal cancer	5.11e-05	0.00011	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—esophageal cancer	5.09e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CREBBP—esophageal cancer	5.09e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—esophageal cancer	5.07e-05	0.000109	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—esophageal cancer	5.01e-05	0.000108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SMAD4—esophageal cancer	4.92e-05	0.000106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—esophageal cancer	4.87e-05	0.000105	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CREBBP—esophageal cancer	4.7e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—esophageal cancer	4.69e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NOS3—esophageal cancer	4.68e-05	0.000101	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—esophageal cancer	4.54e-05	9.76e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—esophageal cancer	4.46e-05	9.6e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—esophageal cancer	4.46e-05	9.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1A—esophageal cancer	4.46e-05	9.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—esophageal cancer	4.44e-05	9.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—esophageal cancer	4.4e-05	9.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—esophageal cancer	4.38e-05	9.42e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—EP300—esophageal cancer	4.36e-05	9.38e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—esophageal cancer	4.28e-05	9.19e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—esophageal cancer	4.26e-05	9.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—esophageal cancer	4.26e-05	9.16e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EP300—esophageal cancer	4.25e-05	9.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—esophageal cancer	4.22e-05	9.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS3—esophageal cancer	4.2e-05	9.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—esophageal cancer	4.03e-05	8.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—esophageal cancer	3.93e-05	8.45e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—esophageal cancer	3.93e-05	8.45e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—esophageal cancer	3.85e-05	8.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—esophageal cancer	3.85e-05	8.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—esophageal cancer	3.84e-05	8.27e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—esophageal cancer	3.7e-05	7.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1A—esophageal cancer	3.64e-05	7.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH1—esophageal cancer	3.63e-05	7.8e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—esophageal cancer	3.62e-05	7.78e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—EP300—esophageal cancer	3.56e-05	7.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EP300—esophageal cancer	3.46e-05	7.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1A—esophageal cancer	3.36e-05	7.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CREBBP—esophageal cancer	3.29e-05	7.07e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—esophageal cancer	3.23e-05	6.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EP300—esophageal cancer	3.2e-05	6.87e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—esophageal cancer	3.14e-05	6.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—esophageal cancer	2.95e-05	6.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOS3—esophageal cancer	2.94e-05	6.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—esophageal cancer	2.79e-05	5.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—esophageal cancer	2.75e-05	5.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—esophageal cancer	2.73e-05	5.86e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—esophageal cancer	2.63e-05	5.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—esophageal cancer	2.56e-05	5.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—esophageal cancer	2.43e-05	5.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—esophageal cancer	2.37e-05	5.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1A—esophageal cancer	2.35e-05	5.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EP300—esophageal cancer	2.24e-05	4.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—esophageal cancer	1.95e-05	4.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—esophageal cancer	1.91e-05	4.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—esophageal cancer	1.66e-05	3.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—esophageal cancer	1.6e-05	3.45e-05	CbGpPWpGaD
